Profil
Rhiannon Jones currently works at Amplia Therapeutics Ltd., as Chief Operating Officer from 2022.
Dr. Jones also formerly worked at Oncology One Pty Ltd., as Director-Operations & Governance from 2016 to 2021 and The Walter & Eliza Hall Institute of Medical Research, as Project Manager from 2013 to 2016.
Dr. Jones received her undergraduate degree and doctorate degree from the University of Adelaide.
Aktive Positionen von Rhiannon Jones
| Unternehmen | Position | Beginn |
|---|---|---|
| AMPLIA THERAPEUTICS LIMITED | Geschäftsführer | 01.02.2021 |
Ehemalige bekannte Positionen von Rhiannon Jones
| Unternehmen | Position | Ende |
|---|---|---|
Oncology One Pty Ltd.
Oncology One Pty Ltd. BiotechnologyHealth Technology Develops novel oncology drug and clinical diseases for cancer | Geschäftsführer | 01.02.2021 |
The Walter & Eliza Hall Institute of Medical Research
The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Corporate Officer/Principal | 01.04.2016 |
Ausbildung von Rhiannon Jones
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Oncology One Pty Ltd.
Oncology One Pty Ltd. BiotechnologyHealth Technology Develops novel oncology drug and clinical diseases for cancer | Health Technology |
The Walter & Eliza Hall Institute of Medical Research
The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
University of Adelaide
University of Adelaide Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amplia Therapeutics Ltd.
Amplia Therapeutics Ltd. BiotechnologyHealth Technology Develops drug candidates for oncology and chronic fibrosis | Health Technology |
















